Tiina Titma
Saatja: Tiina Titma
Saatmisaeg: neljapäev, 1. juuli 2021 14:38
Adressaat: '
[email protected]'
Teema: RE: Question about used solutions on local market allowing sales of medicinal
products produced for other countries (package, leaflet in other language)
Dear Mr Tomasz Kieczewski.
Thank You for addressing that particular important question.
In regard to Estonian law, we have some provisions which could apply.
According to Estonian Medicinal Products Act § 64 and 2001/83/EÜ art 63(3)
(31) Where a medicinal product is not distributed directly to patients or where medicinal products with the
same active substance and of the same strength are not distributed in Estonia and ensuring the continuous
supply of the medicinal product is important from the point of view of human or animal health, the State
Agency of Medicines may, at the request of the marketing authorisation holder and on the condition that
appropriate measures for ensuring the safe use of the medicinal product are taken, authorise the omission
of some required information from the packaging and from the package leaflet of the medicinal product or
authorise the distribution of the medicinal product in packaging and with a package leaflet in the language
of another member state of the European Economic Area.
In addition, according to § 20
(6) As an extraordinary measure, the State Agency of Medicines may ban the export of a medicinal
product where the continuous supply of the medicinal product is important from the point of view of human
or animal health and where other medicinal products with the same active substance and strength are
either not distributed or are distributed in an insufficient quantity in Estonia.
We will be delighted to answer any additional questions.
With Kind Regards
Tiina Titma
Ravimiosakonna nõunik
Ravimiosakond
Sotsiaalministeerium
Suur-Ameerika 1, Tallinn 10122
Telefon: 626 9147
E-post:
[email protected]
Saatja: Tomasz Kiełczewski (PEX PharmaSequence)
<
[email protected]>
Saadetud: 14.05.2021 20:02
Adressaat: SM Info <
[email protected]>
Teema: Question about used solutions on local market allowing sales of medicinal products produced for other
countries (package, leaflet in other language)
Dear Sir or Madam,
Recently we were asked if there are any legal solutions (ad-hoc and systemic ones) used in European countries to
secure availability of the medicines / medical products, if there is a lack of packages manufactured for given country
(example: vaccines manufactured for the given country are over - is it allowed by law to introduce on the market
vaccines produced for other market?)
1
I would be grateful, if you could share with me following information: - are there any solutions used in your country
to solve mentioned above issue (especially those other than parallel import);
- if yes, then what kind;
- what are the legal basis for solution / solutions mentioned above - what conditions should be met by
manufacturer / distributor to become permission for introduction on the market packages from other countries.
If I should refer with my questions to other person / organization in your country, I would by grateful if you could
share with me relevant contact details (e-mail address)
Thanks in advance.
Kind regards,
Tomasz Kie³czewski
Deputy Director of Consulting and Analysis Department
+48 601 293 443
e-mail:
[email protected]
PEX PharmaSequence Sp. z o.o.
23 K³obucka Street 02-699 Warsaw, Poland
phone: +48 22 886 47 15 fax: +48 22 638 21 29
2